Prognostic value of <i>BCL2</i> and <i>TP53</i> genetic alterations for diffuse large B-cell lymphoma patients treated with R-CHOP.

Cancer Biol Med · 2021 · PMC9257313 · PMID 34806851

Europe PMC DOI

hedged sentences

0.0580

closest p · 1.2× alpha

0.0820

boldest claim

The sentences

did not reach statistical significanceP = 0.058so close (0.05 < p ≤ 0.1)

NOTCH1 alterations and MYD88 mutations also tended to be more frequently found in non-GCB subtypes, but these did not reach statistical significance ( P = 0.058 and P = 0.057, respectively).

also in 111,027 other papers

showed a trendP = 0.082so close (0.05 < p ≤ 0.1)

However, MYC alterations showed a trend, occurring more frequently in the GCB subtype ( P = 0.082).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.